Last Updated: August 10, 2026

List of Excipients in API nintedanib


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing nintedanib

Company Ingredient NDC Excipient
Sandoz Inc nintedanib 0781-2492 AMMONIA
Sandoz Inc nintedanib 0781-2492 BUTYL ALCOHOL
Sandoz Inc nintedanib 0781-2492 CARMINIC ACID
Sandoz Inc nintedanib 0781-2492 FERRIC OXIDE RED
Sandoz Inc nintedanib 0781-2492 FERRIC OXIDE YELLOW
Sandoz Inc nintedanib 0781-2492 GELATIN
Sandoz Inc nintedanib 0781-2492 GLYCERIN
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for nintedanib

Excipient focus: AMMONIA

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARMINIC ACID

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GELATIN TYPE B BOVINE

Excipient focus: GLYCERIN

Excipient focus: HARD FAT

Excipient focus: HYDROGENATED PALM/PALM KERNEL OIL PEG-6 ESTERS

nintedanib drug variants not containing HYDROGENATED PALM/PALM KERNEL OIL PEG-6 ESTERS

Company Ingredient NDC
Sandoz Inc nintedanib 0781-2492
Edenbridge Pharmaceuticals LLC nintedanib 42799-972
EPIC PHARMA LLC nintedanib 42806-569
Dr Reddy's Laboratories Inc nintedanib 43598-148
Golden State Medical Supply Inc nintedanib 51407-984
Glenmark Pharmaceuticals Inc USA nintedanib 68462-803
Cipla USA Inc nintedanib 69097-641
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYGLYCERYL-3 DIOLEATE

Excipient focus: POLYSORBATE 80

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SORBITAN MONOOLEATE

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: SOYBEAN LECITHIN

Excipient focus: SOYBEAN PHOSPHATIDYLCHOLINE

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links